Updated Results form to correct NTA

Template
Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)
Updated as at 17 October 2019


Results for announcement to the market
Name of issuer Rua Bioscience Limited
Reporting Period 6 months to December 2022
Previous Reporting Period 6 months to December 2021
Currency NZD
Amount (000s) Percentage change
Revenue from continuing
operations
$ 254 -29%
Total Revenue $ 254 -29 %
Net profit/(loss) from
continuing operations
$ 719 +129%
Total net profit/(loss) $ 719 +129 %
Interim/Final Dividend
Amount per Quoted Equity
Security
N/A
Imputed amount per Quoted
Equity Security
N/A
Record Date N/A
Dividend Payment Date N/A
Current period Prior comparable period
Net tangible assets per
Quoted Equity Security
$0.07 $0.16
A brief explanation of any of
the figures above necessary
to enable the figures to be
understood

Authority for this announcement
Name of person authorised
to make this announcement
Hamish White, Chief Financial Officer
Contact person for this
announcement
Kerry Donovan, Communications and Corporate Affairs
Manager
Contact phone number 021 128 7689
Contact email address info@ruabio.com
Date of release through MAP 01/03/2023